On the other hand, some DEGs promoting tumor cell survival were also shown in the comparison between overall p63+ and p63− DLBCL patients, which may be due to the oncogenic function provided by MUT-p53 or p63 isoforms in the p63+ DLBCL subsets. The gene discussed is TP53; the disease is neoplasm.